NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-343-2002-0-LI-15 GAMMA PGA CONJUGATES FOR ELICITING IMMUNE RESPONSED DIRECTED AGAINST BACILLI LI EP 04754360.8 Abandoned
NICHD E-343-2002-0-LU-16 GAMMA PGA CONJUGATES FOR ELICITING IMMUNE RESPONSED DIRECTED AGAINST BACILLI LU EP 04754360.8 Abandoned
NICHD E-343-2002-0-CH-09 GAMMA PGA CONJUGATES FOR ELICITING IMMUNE RESPONSED DIRECTED AGAINST BACILLI CH EP 04754360.8 Abandoned
NICHD E-343-2002-0-GB-12 GAMMA PGA CONJUGATES FOR ELICITING IMMUNE RESPONSED DIRECTED AGAINST BACILLI GB EP 04754360.8 Abandoned
NICHD E-343-2002-0-IE-13 GAMMA PGA CONJUGATES FOR ELICITING IMMUNE RESPONSED DIRECTED AGAINST BACILLI IE EP 04754360.8 Abandoned
NICHD E-343-2002-0-IT-14 GAMMA PGA CONJUGATES FOR ELICITING IMMUNE RESPONSED DIRECTED AGAINST BACILLI IT EP 04754360.8 Abandoned
NICHD E-343-2002-0-AU-06 POLY-GAMMA-GLUTAMIC CONJUGATES FOR ELICITING IMMUNE RESPONSES DIRECTED AGAINST BACILLI AU National Stage 2004252091 Abandoned
NICHD E-343-2002-0-PCT-02 GAMMA PGA CONJUGATES FOR ELICITING IMMUNE RESPONSED DIRECTED AGAINST BACILLI PCT PCT PCT/US2004/17736 Expired
NIDCD E-174-2004-0-US-01 Moraxella (or Branhamella) Catarrhalis Is Viable Without Endotoxin, A Potential Vaccine Candidate US 60/577,244 Abandoned
NCI E-306-2004-0-US-01 A Transposon-based System For Cancer Gene Identification In Mice US 60/577,000 Abandoned
NIAAA E-007-2003-2-EP-05 NUTRITIONAL SUPPLEMENTS AND THERAPEUTIC COMPOSITIONS COMPRISING (R)-3-HYDROXYBUTYRATE DERIVATIVES EP National Stage 04754584.3 Expired
NIAAA E-007-2003-2-CA-03 NUTRITIONAL SUPPLEMENTS AND THERAPEUTIC COMPOSITIONS COMPRISING (R) -3- HYDROXYBUTYRATE DERIVATIVES CA National Stage 2527940 Expired
NIAAA E-007-2003-2-AU-04 NUTRITIONAL SUPPLEMENTS AND THERAPEUTIC COMPOSITIONS COMPRISING (R)-3-HYDROXYBUTYRATE DERIVATIVES AU National Stage 2004245567 Expired
NIAAA E-007-2003-2-PCT-01 Synthesis Of The Monoester Of 1,3 Butandiol With A Trimer Of D-Beta-Hydroxybutayrate Using Lipase Catalysis In Nonaqueous Media And Modifications Of This And Other Esters PCT PCT COMB PCT/US2004/018016 Expired
NCI E-317-2001-0-US-03 Compounds to Treat HIV Infection and Aids US National Stage 10/497,898 Abandoned
NIA E-203-2006-0-US-01 Methods Of Screening For Cell Proliferation Disorders US 60/576,566 Abandoned
NCI E-116-2003-0-PCT-02 Immunogenic Peptides for the Treatment of Prostrate and Breast Cancer PCT PCT PCT/US2004/017574 Expired
NIAID E-048-2004-1-US-01 High Efficiency Expression System For TGFbeta-1, TGFbeta-2 and TGFbeta-3 US 60/575,839 Abandoned
NCI E-005-2002-0-DE-06 Gene Expressed in Prostate Cancer and Methods of Use DE EP 02795643.2 Abandoned
NCI E-005-2002-0-FR-07 Gene Expressed in Prostate Cancer and Methods of Use FR EP 02795643.2 Abandoned
NCI E-005-2002-0-GB-08 Gene Expressed in Prostate Cancer and Methods of Use GB EP 02795643.2 Abandoned
NIAID E-224-2004-0-US-01 Glycine As A Protein Stablzer In Montanide ISA 720 Vaccine Formulation US 60/576,361 Abandoned
NCI E-106-2003-0-US-01 Griffithsins and Related conjucages, Fusion Proteins, Nucleic Acids, Vectors, Host Cells, Compositions, Antibodies and Methods of Using Griffithsins US 60/576,056 Abandoned
NCI E-074-1999-3-US-09 Glycosylation-Resistant Cyanovirins and related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins. US CON 10/857,158 7339037 Expired PDF
NINDS E-306-2003-0-US-01 Genetic Fingerprint Of Acute Stroke US 60/575,279 Abandoned
NIDCR E-131-1998-0-US-29 Thymosin Beta 4 Compositions US CON 10/853,505 7268118 Expired PDF
NIAID E-066-2003-3-US-01 Isolation And Characterization Of Chimpanzee Monoclonal Antibodies Capable Of Efficiently Neutralizing Dengue Type 1,2,3 And 4 Viruses US 60/574,492 Abandoned
NIDDK E-200-2003-0-US-01 Methods for Making and Using Mass Tag Standards for Quantitative Proteomics US 60/574,612 Abandoned
NIAID E-323-2005-0-US-01 Influenza Hemagglutinin and Neuraminidase Variants US 60/574,553 Abandoned
NIAID E-229-2003-2-JP-13 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof JP National Stage 2006-533390 Expired
NIAID E-229-2003-2-US-02 A Method of Treating or Ameliorating an Immune Cell Associated Pathology Using GITR Ligand Antibodies US ORD 10/853,032 7618632 Issued PDF
NIAID E-229-2003-2-RU-21 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof RU National Stage 2005140279 Abandoned
NCI E-151-2007-2-AU-04 Nucleotide Sequences Of HIV-1 Type (or Subtype) O Retrovirus Antigens AU DIV 2005202281 Expired
NIAID E-233-2003-1-US-03 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein 38 US CON 10/851,637 7537765 Expired PDF
NIAID E-229-2003-2-SG-18 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof SG National Stage 200507155-0 Abandoned
NIAID E-229-2003-2-ZA-19 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof ZA National Stage 2005/09143 Abandoned
NIAID E-229-2003-2-PCT-01 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof PCT PCT COMB PCT/US2004/016381 Expired
NIAID E-229-2003-2-EP-08 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof EP National Stage 04753244.5 Abandoned
NIAID E-229-2003-2-CA-05 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof CA National Stage 2525717 Abandoned
NIAID E-229-2003-2-CO-07 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof CO National Stage 05118453 Abandoned
NIAID E-229-2003-2-IN-10 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof IN National Stage 5176/DELNP/2005 Abandoned
NIAID E-229-2003-2-IL-12 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof IL National Stage 171815 Abandoned
NIAID E-229-2003-2-HK-09 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof HK National Stage 06106679.9 Abandoned
NIAID E-229-2003-2-ID-11 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof ID National Stage W-00200503114 Abandoned
NIAID E-229-2003-2-KR-20 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof KR National Stage 10-2005-7022431 Abandoned
NIAID E-229-2003-2-NO-16 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof NO National Stage 2005-5306 Abandoned
NIAID E-229-2003-2-AU-03 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof AU National Stage 2004244626 Abandoned
NIAID E-229-2003-2-JP-24 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof JP DIV 2010-209408 Abandoned
NIAID E-229-2003-2-VN-22 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof VN National Stage 1-2005-01875 Abandoned
NCI E-207-2004-0-US-01 Plasmids for Homologous Recombination and Methods of Use US 60/573,504 Abandoned